Medpace Holdings, Inc. (MEDP)
MEDP Stock Price Chart
Explore Medpace Holdings, Inc. interactive price chart. Choose custom timeframes to analyze MEDP price movements and trends.
MEDP Company Profile
Discover essential business fundamentals and corporate details for Medpace Holdings, Inc. (MEDP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
11 Aug 2016
Employees
5.90K
Website
https://www.medpace.comCEO
August James Troendle
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
MEDP Financial Timeline
Browse a chronological timeline of Medpace Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 20 Apr 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 20 Oct 2025
EPS estimate is $3.49, while revenue estimate is $640.50M.
Earnings released on 21 Jul 2025
EPS came in at $3.10 surpassing the estimated $3.00 by +3.33%, while revenue for the quarter reached $603.31M , beating expectations by +9.79%.
Earnings released on 21 Apr 2025
EPS came in at $3.67 surpassing the estimated $3.06 by +19.93%, while revenue for the quarter reached $558.57M , beating expectations by +6.12%.
Earnings released on 10 Feb 2025
EPS came in at $3.67 surpassing the estimated $2.96 by +23.99%, while revenue for the quarter reached $536.59M , missing expectations by -0.58%.
Earnings released on 21 Oct 2024
EPS came in at $3.01 surpassing the estimated $2.78 by +8.27%, while revenue for the quarter reached $533.32M , missing expectations by -0.29%.
Earnings released on 22 Jul 2024
EPS came in at $2.75 surpassing the estimated $2.54 by +8.27%, while revenue for the quarter reached $528.10M , missing expectations by -0.06%.
Earnings released on 22 Apr 2024
EPS came in at $3.20 surpassing the estimated $2.47 by +29.55%, while revenue for the quarter reached $511.04M , missing expectations by -0.26%.
Earnings released on 12 Feb 2024
EPS came in at $2.46 surpassing the estimated $2.22 by +10.81%, while revenue for the quarter reached $498.40M , missing expectations by -2.67%.
Earnings released on 23 Oct 2023
EPS came in at $2.22 surpassing the estimated $2.05 by +8.29%, while revenue for the quarter reached $492.50M , beating expectations by +3.52%.
Earnings released on 24 Jul 2023
EPS came in at $1.93 surpassing the estimated $1.91 by +1.05%, while revenue for the quarter reached $460.87M , beating expectations by +2.81%.
Earnings released on 24 Apr 2023
EPS came in at $2.27 surpassing the estimated $1.80 by +26.11%, while revenue for the quarter reached $434.07M , beating expectations by +3.41%.
Earnings released on 13 Feb 2023
EPS came in at $2.12 surpassing the estimated $1.79 by +18.44%, while revenue for the quarter reached $394.10M , beating expectations by +2.09%.
Earnings released on 24 Oct 2022
EPS came in at $2.05 surpassing the estimated $1.47 by +39.46%, while revenue for the quarter reached $383.74M , beating expectations by +7.44%.
Earnings released on 25 Jul 2022
EPS came in at $1.46 surpassing the estimated $1.31 by +11.45%, while revenue for the quarter reached $351.21M , beating expectations by +2.09%.
Earnings released on 25 Apr 2022
EPS came in at $1.69 surpassing the estimated $1.26 by +34.13%, while revenue for the quarter reached $330.95M , beating expectations by +1.18%.
Earnings released on 14 Feb 2022
EPS came in at $1.32 surpassing the estimated $1.25 by +5.60%, while revenue for the quarter reached $308.55M , missing expectations by -0.16%.
Earnings released on 25 Oct 2021
EPS came in at $1.29 surpassing the estimated $1.07 by +20.56%, while revenue for the quarter reached $295.57M , beating expectations by +1.17%.
Earnings released on 26 Jul 2021
EPS came in at $1.06 surpassing the estimated $0.99 by +7.07%, while revenue for the quarter reached $278.29M , missing expectations by -4.74%.
Earnings released on 26 Apr 2021
EPS came in at $1.14 surpassing the estimated $1.00 by +14.00%, while revenue for the quarter reached $259.97M , beating expectations by +16.28%.
Earnings released on 15 Feb 2021
EPS came in at $1.35 surpassing the estimated $1.24 by +8.87%, while revenue for the quarter reached $259.68M , beating expectations by +9.73%.
Earnings released on 26 Oct 2020
EPS came in at $1.09 surpassing the estimated $1.07 by +1.87%, while revenue for the quarter reached $230.37M , beating expectations by +1.87%.
MEDP Stock Performance
Access detailed MEDP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.